SAN DIEGO - Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biotech company currently valued at $171 million, has shared promising clinical data from its studies of azenosertib, a small ...
Ovarian Cancer Research Alliance (OCRA), the world's largest gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research will combine with OCRA, effective ...